Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech Republic

Breast Cancer in a RAD51D Mutation Carrier: Case Report and Review of the Literature

(2015) Jennifer L. Baker et al.   Clinical Breast Cancer

Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan

(2014) Muhammad U. Rashid et al.   BREAST CANCER RESEARCH AND TREATMENT

RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families

(2014) Ana Blanco et al.   BREAST CANCER RESEARCH AND TREATMENT

Frequency of mutations in individuals with breast cancer referred forBRCA1andBRCA2testing using next-generation sequencing with a 25-gene panel

(2014) Nadine Tung et al.   CANCER

Genetic testing and familial implications in breast-ovarian cancer families

(2014) Jan C. Oosterwijk et al.   MATURITAS

Germline mutation in the RAD51B gene confers predisposition to breast cancer

(2013) Lisa Golmard et al.   BMC CANCER

The PALB2 Gene Is a Strong Candidate for Clinical Testing in BRCA1- and BRCA2-Negative Hereditary Breast Cancer

(2013) M. Janatova et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

About 1% of the breast and ovarian Spanish families testing negative forBRCA1andBRCA2are carriers ofRAD51Dpathogenic variants

(2013) Sara Gutiérrez-Enríquez et al.   INTERNATIONAL JOURNAL OF CANCER

Analysis of RAD51D in Ovarian Cancer Patients and Families with a History of Ovarian or Breast Cancer

(2013) Ella R. Thompson et al.   PLoS One

Genetic Testing by Cancer Site

(2012) Scott M. Weissman et al.   CANCER JOURNAL

GermlineRAD51Cmutations in ovarian cancer susceptibility

(2012) F Coulet et al.   CLINICAL GENETICS

Hereditary ovarian cancer: Beyond the usual suspects

(2012) Kathryn P. Pennington et al.   GYNECOLOGIC ONCOLOGY

Loss of function germline mutations in RAD51D in women with ovarian carcinoma

(2012) Anneka Wickramanyake et al.   GYNECOLOGIC ONCOLOGY

A Finnish founder mutation inRAD51D: analysis in breast, ovarian, prostate, and colorectal cancer: Table 1

(2012) Liisa M Pelttari et al.   JOURNAL OF MEDICAL GENETICS

Germline RAD51C mutations confer susceptibility to ovarian cancer

(2012) Chey Loveday et al.   NATURE GENETICS

RAD51C is a susceptibility gene for ovarian cancer

(2011) Liisa M. Pelttari et al.   HUMAN MOLECULAR GENETICS

Germline mutations in RAD51D confer susceptibility to ovarian cancer

(2011) Chey Loveday et al.   NATURE GENETICS

RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer

(2010) K. Somyajit et al.   CARCINOGENESIS

Mutation of the RAD51C gene in a Fanconi anemia–like disorder

(2010) Fiona Vaz et al.   NATURE GENETICS

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

(2010) Alfons Meindl et al.   NATURE GENETICS

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing

(2010) Tom Walsh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population

(2008) Zdenek Kleibl et al.   EUROPEAN JOURNAL OF CANCER

The emerging landscape of breast cancer susceptibility

(2007) Michael R Stratton et al.   NATURE GENETICS